Seeing Is Believing
Currently out of the existing stock ratings of Nicholas Holowko, 27 are a BUY (40.3%), 38 are a HOLD (56.72%), 2 are a SELL (2.99%).
Analyst Nicholas Holowko, currently employed at RAYMOND JAMES, carries an average stock price target met ratio of 72.81% that have a potential upside of 17.36% achieved within 172 days. Previously, Nicholas Holowko worked at UBS.
Nicholas Holowko’s has documented 132 price targets and ratings displayed on 20 stocks. The coverage is on Financial Services, Healthcare sectors.
Most recent stock forecast was given on ALLY, Ally Financial at 06-Oct-2026.
Analyst best performing recommendations are on CMA (COMERICA).
The best stock recommendation documented was for CMA (COMERICA) at 7/21/2025. The price target of $64 was fulfilled within 1 day with a profit of $1.97 (3.18%) receiving and performance score of 31.76.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 10-Aug-2026
$190
$32.22 (20.42%)
$195
Buy Since 01-Dec-2023
$193
$35.22 (22.32%)
$192
17 days ago
(26-Oct-2026)
10/14 (71.43%)
$32.59 (20.32%)
278
Buy Since 15-Jan-2026
$190
$32.22 (20.42%)
$198
17 days ago
(26-Oct-2026)
2/5 (40%)
$29.59 (18.45%)
118
Buy Since 25-Apr-2024
$205
$47.22 (29.93%)
$200
1 months 7 days ago
(05-Oct-2026)
11/16 (68.75%)
$46.18 (29.08%)
271
Buy Since 08-Apr-2016
$216
$58.22 (36.90%)
$214
2 months 12 days ago
(31-Aug-2026)
7/10 (70%)
$48.73 (29.13%)
785
Which stock is Nicholas Holowko most bullish on?
Which stock is Nicholas Holowko most reserved on?
What Year was the first public recommendation made by Nicholas Holowko?